Dear Valued Members,
We are pleased to announce that the Universe of stocks available for SPA3 Investor has been increased.
There are now an additional 12 stocks on the ASX and 14 stocks in the US that can be used with the SPA3 Investor methodology, bringing the total number of stocks to 42 and 44 respectively.
Some of our eagle-eyed members may already be aware of this. However, for the greater understanding of all our members, the additional stocks for both the Australian and the US markets are outlined below:
ASX stocks: CIM, FPH, MND, RMD, SEK, WOR, WHC, MIN, DMP, SAR, EVN, NST
USA stocks: AAXN, AMD, BIDU, CRM, DIS, DXCM, HFC, LRCX, MELI, NTES, TSLA, SQM, TTWO, UAL
These stocks will already be available on the SWS Alerts App (*Only users with a US data subscription will have access to the US stocks.)
With regards to Beyond Charts, if you have not opened the program in recent weeks you will need to go through the steps below to allow the update to take effect:
Open Beyond Charts and Leave it Open for a few minutes. (This allows the necessary update script to be downloaded to your system)
Shutdown Beyond Charts.
Open Beyond Charts again (upon re-opening Beyond Charts, the update script will run and the necessary changes will be applied)
Once the update is complete, you can view the full list of stocks at any time via the Industry Watch Lists Panel in Beyond Charts. Look for “SWS ASX Stocks for SPA3 Investor” & “SWS USA Stocks for SPA3 Investor”. (*Only users with a US data subscription will have access to the US stocks.)
If you have performed the steps outlined above and are still unable to view the updated Watch Lists in Beyond Charts, please contact the support team on 03 9585 0300 or email us at email@example.com.
Please note, the addition of these stocks does not change any of the research with regards to the optimal number of positions one should hold in their US or AUS Equal Weighted Stocks Portfolio. It simply provides a greater list to choose from. You can re-visit this research here.
As always, please feel free to continue the discussion below.